Results 91 to 100 of about 21,287 (236)
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease, with afflicted patients often progressing to end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT).
Brandon Budhram +9 more
doaj +1 more source
Ouabain enhances ADPKD cell apoptosis via the intrinsic pathway [PDF]
Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly influenced by factors circulating in blood. We have shown that the hormone ouabain enhances several characteristics of the ADPKD cystic phenotype, including the rate of cell ...
Gustavo Blanco +3 more
core +1 more source
Extrarenal manifestations of ADPKD
A 47-year-old woman was evaluated in the Nephrology Clinic at New England Medical Center for autosomal dominant polycystic kidney disease (ADPKD). She had undergone abdominal and pelvic noncontrast computed tomographic scans for the evaluation of dyspareunia and stress incontinence.
openaire +2 more sources
Severe parental phenotype associates with hypertension in children with ADPKD.
Early detection of hypertension in children with autosomal polycystic kidney disease (ADPKD) may be beneficial, but screening children at risk of ADPKD remains controversial.
Nathalie Demoulin +15 more
core +1 more source
Extrarenale Manifestationen der autosomal dominanten polyzystischen Nierenerkrankung (ADPKD) [PDF]
Die autosomal dominante polyzystische Nierenerkrankung (ADPKD) ist eine chronisch fortschreitende Systemerkrankung, die bei mehr als 75 % der Betroffenen zu einem Nierenversagen als zentraler Manifestation führt.
Arjune, Sita
core
Hypertension is a common early finding in autosomal dominant polycystic kidney disease (ADPKD). Improvements in screening and diagnosis of ADPKD have allowed earlier diagnosis, later onset of end-stage renal disease, and better survival.
Imed Helal +3 more
doaj +1 more source
Polycystin 2: a calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD
Polycystin 2 (PC2) is one of two main protein types responsible for the underlying etiology of autosomal dominant polycystic kidney disease (ADPKD), the most prevalent monogenic renal disease in the world.
Allison L. Brill, B. Ehrlich
semanticscholar +1 more source
Background and objectives ADPKD is erroneously perceived as a not rare condition, which is mainly due to the repeated citation of a mistaken interpretation of old epidemiological data, as reported in the Dalgaard's work (1957).
Andrea Solazzo +11 more
semanticscholar +1 more source
Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles
Background Autosomal Dominant Polycystic Kidney Disease (ADPKD) is one of the most common causes of end-stage renal failure, caused by mutations in PKD1 or PKD2 genes. Tolvaptan, the only drug approved for ADPKD treatment, results in serious side-effects,
Tareq B. Malas +8 more
semanticscholar +1 more source
INTRODUCTION AND AIMS: In 7 to 10% of ADPKD patients no mutation of the PKD1 and PKD2 genes is identified. The recent description of GANAB, encoding the α subunit of the glucosidase II, where mutations impair polycystin trafficking, indicate further ...
Yannick Le Meur +13 more
core +1 more source

